 Joanne Masterson
Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 24 | 2025 | 330 | 7.130 |
Why?
| | Eosinophils | 17 | 2021 | 316 | 2.930 |
Why?
| | Eosinophilia | 10 | 2022 | 221 | 2.650 |
Why?
| | Epithelial Cells | 13 | 2025 | 1125 | 2.350 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2025 | 297 | 2.020 |
Why?
| | Claudins | 3 | 2024 | 23 | 1.930 |
Why?
| | Enteritis | 4 | 2022 | 103 | 1.700 |
Why?
| | MicroRNAs | 6 | 2024 | 701 | 1.440 |
Why?
| | Tight Junctions | 4 | 2024 | 81 | 1.380 |
Why?
| | Gastroesophageal Reflux | 5 | 2023 | 236 | 1.350 |
Why?
| | Esophagus | 11 | 2024 | 261 | 1.320 |
Why?
| | Gastritis | 4 | 2022 | 115 | 1.200 |
Why?
| | Esophagitis | 2 | 2018 | 66 | 1.020 |
Why?
| | 5'-Nucleotidase | 1 | 2025 | 49 | 0.910 |
Why?
| | Colitis | 8 | 2024 | 280 | 0.890 |
Why?
| | Keratins | 2 | 2024 | 172 | 0.840 |
Why?
| | Hypersensitivity | 4 | 2024 | 252 | 0.840 |
Why?
| | Adenosine | 1 | 2025 | 255 | 0.810 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 210 | 0.780 |
Why?
| | Claudin-1 | 2 | 2019 | 15 | 0.720 |
Why?
| | Esophageal Mucosa | 2 | 2019 | 22 | 0.660 |
Why?
| | Barrett Esophagus | 1 | 2023 | 165 | 0.640 |
Why?
| | Intestines | 2 | 2021 | 358 | 0.630 |
Why?
| | Fibrosis | 3 | 2024 | 548 | 0.630 |
Why?
| | Ileitis | 4 | 2015 | 33 | 0.610 |
Why?
| | Eosinophil Peroxidase | 2 | 2018 | 9 | 0.600 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 347 | 0.580 |
Why?
| | Gastrointestinal Diseases | 2 | 2019 | 216 | 0.580 |
Why?
| | Disease Models, Animal | 12 | 2024 | 4557 | 0.550 |
Why?
| | Mice, Transgenic | 5 | 2024 | 2182 | 0.540 |
Why?
| | Ileum | 2 | 2015 | 111 | 0.540 |
Why?
| | Cell Differentiation | 2 | 2024 | 2050 | 0.530 |
Why?
| | Receptors, CCR3 | 2 | 2018 | 7 | 0.490 |
Why?
| | Macrophages | 1 | 2024 | 1511 | 0.490 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2017 | 178 | 0.480 |
Why?
| | Signal Transduction | 8 | 2025 | 5226 | 0.470 |
Why?
| | Anti-Inflammatory Agents | 3 | 2014 | 474 | 0.470 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 161 | 0.470 |
Why?
| | Mice | 22 | 2025 | 18339 | 0.460 |
Why?
| | Crohn Disease | 4 | 2015 | 260 | 0.460 |
Why?
| | Interleukin-33 | 1 | 2015 | 45 | 0.460 |
Why?
| | Vascular Remodeling | 1 | 2017 | 205 | 0.430 |
Why?
| | Animals | 28 | 2025 | 38058 | 0.430 |
Why?
| | Epithelium | 5 | 2019 | 314 | 0.430 |
Why?
| | Inflammation | 7 | 2024 | 2878 | 0.420 |
Why?
| | Intestinal Mucosa | 7 | 2016 | 676 | 0.410 |
Why?
| | Acute Lung Injury | 3 | 2024 | 303 | 0.400 |
Why?
| | Humans | 47 | 2025 | 144759 | 0.380 |
Why?
| | Th1 Cells | 3 | 2024 | 139 | 0.380 |
Why?
| | Interleukin-5 | 1 | 2012 | 39 | 0.370 |
Why?
| | Celiac Disease | 1 | 2015 | 308 | 0.350 |
Why?
| | Asthma | 2 | 2021 | 1767 | 0.340 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2010 | 43 | 0.340 |
Why?
| | Leukocyte Count | 3 | 2021 | 316 | 0.330 |
Why?
| | Myeloid Cells | 2 | 2024 | 148 | 0.320 |
Why?
| | Cadherins | 3 | 2010 | 201 | 0.310 |
Why?
| | Regeneration | 1 | 2010 | 197 | 0.280 |
Why?
| | Cell Line, Transformed | 2 | 2019 | 140 | 0.270 |
Why?
| | Bromodeoxyuridine | 1 | 2007 | 79 | 0.270 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 73 | 0.260 |
Why?
| | Lung | 4 | 2018 | 4109 | 0.260 |
Why?
| | DNA, Neoplasm | 1 | 2007 | 163 | 0.250 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2007 | 105 | 0.250 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 109 | 0.250 |
Why?
| | Child | 18 | 2021 | 22633 | 0.250 |
Why?
| | Male | 22 | 2025 | 72315 | 0.250 |
Why?
| | Hypoxia | 2 | 2024 | 1199 | 0.240 |
Why?
| | GPI-Linked Proteins | 1 | 2025 | 80 | 0.230 |
Why?
| | DNA Damage | 1 | 2007 | 430 | 0.210 |
Why?
| | Cell Cycle | 1 | 2007 | 596 | 0.210 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2024 | 59 | 0.200 |
Why?
| | Protein Processing, Post-Translational | 1 | 2007 | 477 | 0.200 |
Why?
| | Cell Line | 4 | 2025 | 2882 | 0.200 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 31 | 0.200 |
Why?
| | Cell Hypoxia | 1 | 2024 | 247 | 0.200 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5992 | 0.190 |
Why?
| | Child, Preschool | 9 | 2019 | 11787 | 0.190 |
Why?
| | Hypercapnia | 1 | 2023 | 54 | 0.190 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 11 | 0.190 |
Why?
| | Female | 21 | 2024 | 78271 | 0.190 |
Why?
| | Wound Healing | 1 | 2025 | 351 | 0.190 |
Why?
| | Biomarkers | 6 | 2024 | 4271 | 0.180 |
Why?
| | Glycolysis | 1 | 2024 | 339 | 0.180 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2022 | 37 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2016 | 142 | 0.180 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2024 | 557 | 0.170 |
Why?
| | Adolescent | 13 | 2019 | 22428 | 0.170 |
Why?
| | Dexamethasone | 3 | 2012 | 372 | 0.170 |
Why?
| | Biopsy | 4 | 2019 | 1075 | 0.170 |
Why?
| | Immunoglobulin G | 2 | 2018 | 893 | 0.170 |
Why?
| | Disease Progression | 3 | 2023 | 2847 | 0.160 |
Why?
| | Chemokines | 2 | 2024 | 218 | 0.160 |
Why?
| | GATA3 Transcription Factor | 2 | 2018 | 22 | 0.160 |
Why?
| | Homeostasis | 2 | 2021 | 640 | 0.150 |
Why?
| | Cytokines | 4 | 2016 | 2061 | 0.140 |
Why?
| | Antibodies, Monoclonal | 3 | 2017 | 1519 | 0.140 |
Why?
| | Protein Stability | 1 | 2019 | 178 | 0.140 |
Why?
| | Colonic Diseases | 1 | 2018 | 34 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 983 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
| | Phenotype | 3 | 2022 | 3162 | 0.130 |
Why?
| | Microbiota | 2 | 2016 | 781 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2023 | 3604 | 0.130 |
Why?
| | Cell Movement | 5 | 2018 | 965 | 0.130 |
Why?
| | Proteomics | 1 | 2024 | 1195 | 0.130 |
Why?
| | Nanoparticles | 3 | 2018 | 519 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2012 | 341 | 0.130 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2017 | 7 | 0.130 |
Why?
| | Electric Impedance | 1 | 2017 | 111 | 0.130 |
Why?
| | Chemokine CCL24 | 2 | 2019 | 11 | 0.130 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2608 | 0.130 |
Why?
| | Mucous Membrane | 3 | 2013 | 127 | 0.130 |
Why?
| | Antibodies | 2 | 2017 | 401 | 0.130 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 488 | 0.130 |
Why?
| | Gene Expression | 2 | 2023 | 1490 | 0.120 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 208 | 0.120 |
Why?
| | Smad Proteins | 1 | 2016 | 43 | 0.120 |
Why?
| | Mice, Knockout | 5 | 2024 | 3121 | 0.120 |
Why?
| | Probiotics | 1 | 2016 | 61 | 0.120 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 169 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2023 | 928 | 0.120 |
Why?
| | G(M1) Ganglioside | 1 | 2015 | 8 | 0.120 |
Why?
| | Inflammasomes | 1 | 2017 | 146 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 920 | 0.110 |
Why?
| | Colon | 1 | 2018 | 304 | 0.110 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2015 | 558 | 0.110 |
Why?
| | Peroxidase | 1 | 2015 | 168 | 0.110 |
Why?
| | Down-Regulation | 1 | 2017 | 627 | 0.110 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 635 | 0.110 |
Why?
| | Fibronectins | 1 | 2015 | 136 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 69 | 0.110 |
Why?
| | Mice, Inbred C3H | 2 | 2016 | 251 | 0.110 |
Why?
| | Desmosomes | 1 | 2014 | 22 | 0.110 |
Why?
| | Receptor, Adenosine A2B | 1 | 2015 | 65 | 0.110 |
Why?
| | Interleukin-13 | 1 | 2015 | 144 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2017 | 375 | 0.110 |
Why?
| | Neutrophils | 2 | 2017 | 1134 | 0.110 |
Why?
| | Constriction, Pathologic | 1 | 2015 | 248 | 0.110 |
Why?
| | Dextran Sulfate | 3 | 2024 | 92 | 0.110 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 178 | 0.110 |
Why?
| | Th2 Cells | 2 | 2018 | 171 | 0.110 |
Why?
| | Permeability | 2 | 2011 | 168 | 0.110 |
Why?
| | Bronchi | 1 | 2016 | 267 | 0.100 |
Why?
| | RNA, Bacterial | 1 | 2015 | 189 | 0.100 |
Why?
| | Trachea | 1 | 2016 | 261 | 0.100 |
Why?
| | Th17 Cells | 1 | 2015 | 101 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2017 | 365 | 0.100 |
Why?
| | Autophagy | 1 | 2016 | 286 | 0.100 |
Why?
| | beta-Defensins | 1 | 2013 | 22 | 0.100 |
Why?
| | Oxazolone | 1 | 2012 | 5 | 0.100 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 27 | 0.100 |
Why?
| | Collagen | 1 | 2015 | 456 | 0.100 |
Why?
| | Inflammation Mediators | 1 | 2015 | 509 | 0.090 |
Why?
| | Mucositis | 1 | 2012 | 20 | 0.090 |
Why?
| | Pregnenediones | 1 | 2012 | 14 | 0.090 |
Why?
| | Peptides | 1 | 2018 | 995 | 0.090 |
Why?
| | Ischemia | 1 | 2015 | 421 | 0.090 |
Why?
| | Chemokine CCL19 | 1 | 2012 | 6 | 0.090 |
Why?
| | Chemokine CCL21 | 1 | 2012 | 13 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 467 | 0.090 |
Why?
| | Adult | 8 | 2021 | 40449 | 0.090 |
Why?
| | Choristoma | 1 | 2012 | 21 | 0.090 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2015 | 389 | 0.090 |
Why?
| | Anti-Allergic Agents | 1 | 2012 | 40 | 0.090 |
Why?
| | Chemokine CCL11 | 1 | 2011 | 25 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2017 | 4154 | 0.090 |
Why?
| | Herpesvirus 4, Human | 1 | 2012 | 176 | 0.090 |
Why?
| | Kidney Diseases | 1 | 2015 | 427 | 0.090 |
Why?
| | Neutrophil Infiltration | 1 | 2011 | 104 | 0.080 |
Why?
| | Neoplasms | 1 | 2007 | 2875 | 0.080 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 78 | 0.080 |
Why?
| | Smad Proteins, Receptor-Regulated | 1 | 2010 | 2 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 397 | 0.080 |
Why?
| | Fibroblasts | 1 | 2016 | 1034 | 0.080 |
Why?
| | Naphthalenes | 1 | 2010 | 56 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 138 | 0.080 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 219 | 0.080 |
Why?
| | Up-Regulation | 1 | 2012 | 851 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2012 | 415 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 321 | 0.070 |
Why?
| | Infant | 3 | 2018 | 10034 | 0.070 |
Why?
| | Flow Cytometry | 4 | 2015 | 1173 | 0.070 |
Why?
| | beta-Galactosidase | 1 | 2007 | 77 | 0.070 |
Why?
| | Kidney | 1 | 2015 | 1495 | 0.070 |
Why?
| | Monocytes | 2 | 2023 | 538 | 0.070 |
Why?
| | Interleukin-1 | 1 | 2011 | 961 | 0.070 |
Why?
| | Mesoderm | 1 | 2008 | 150 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1489 | 0.060 |
Why?
| | Matrix Metalloproteinases | 1 | 2007 | 98 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2018 | 17066 | 0.060 |
Why?
| | Pneumonia | 2 | 2024 | 631 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1813 | 0.060 |
Why?
| | Azoxymethane | 1 | 2024 | 17 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2527 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2024 | 111 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 106 | 0.050 |
Why?
| | Cellular Microenvironment | 1 | 2024 | 94 | 0.050 |
Why?
| | Genes, Mitochondrial | 1 | 2023 | 13 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 628 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2008 | 2496 | 0.050 |
Why?
| | Carcinogenesis | 1 | 2024 | 229 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 370 | 0.050 |
Why?
| | Esophagoscopy | 2 | 2016 | 221 | 0.050 |
Why?
| | Carnitine | 1 | 2023 | 90 | 0.050 |
Why?
| | Interleukin-1beta | 2 | 2017 | 395 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2730 | 0.050 |
Why?
| | Rats | 1 | 2010 | 5597 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2023 | 242 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 299 | 0.040 |
Why?
| | International Cooperation | 1 | 2021 | 198 | 0.040 |
Why?
| | Acute Disease | 2 | 2015 | 1030 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 780 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 450 | 0.040 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 10 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 863 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3540 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1217 | 0.030 |
Why?
| | Endoscopy, Digestive System | 1 | 2019 | 140 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1129 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1985 | 0.030 |
Why?
| | RNA Transport | 1 | 2017 | 27 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 2018 | 153 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 86 | 0.030 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 39 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 336 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2832 | 0.030 |
Why?
| | Middle Aged | 4 | 2021 | 35875 | 0.030 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 60 | 0.030 |
Why?
| | Chloroquine | 1 | 2016 | 53 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 194 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 98 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 324 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2016 | 191 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 630 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2017 | 348 | 0.030 |
Why?
| | Respiratory System | 1 | 2016 | 149 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 121 | 0.030 |
Why?
| | Allergens | 1 | 2018 | 384 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1095 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 248 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2015 | 198 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2014 | 157 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2015 | 99 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 381 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 14105 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 392 | 0.030 |
Why?
| | Isoenzymes | 1 | 2015 | 299 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2637 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 610 | 0.030 |
Why?
| | Base Sequence | 1 | 2017 | 2190 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 383 | 0.020 |
Why?
| | Eosinophil Granule Proteins | 1 | 2012 | 15 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 43 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1253 | 0.020 |
Why?
| | Lysophospholipase | 1 | 2012 | 10 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1187 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 23 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2012 | 166 | 0.020 |
Why?
| | Diet Therapy | 1 | 2012 | 37 | 0.020 |
Why?
| | Vimentin | 1 | 2012 | 54 | 0.020 |
Why?
| | Protein Binding | 1 | 2018 | 2273 | 0.020 |
Why?
| | Netrin-1 | 1 | 2011 | 15 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 113 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 555 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 549 | 0.020 |
Why?
| | Metagenome | 1 | 2012 | 149 | 0.020 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2011 | 30 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2012 | 80 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2011 | 52 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 499 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 155 | 0.020 |
Why?
| | Remission Induction | 1 | 2012 | 307 | 0.020 |
Why?
| | Specimen Handling | 1 | 2012 | 186 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 530 | 0.020 |
Why?
| | Glycoproteins | 1 | 2012 | 355 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1257 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 769 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 536 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 316 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 851 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 824 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 479 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2016 | 1339 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2012 | 478 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 3185 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1306 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 771 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1716 | 0.020 |
Why?
| | Immunologic Memory | 1 | 2010 | 366 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7990 | 0.020 |
Why?
| | Cytoskeleton | 1 | 2008 | 195 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2008 | 416 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3409 | 0.010 |
Why?
| | Cell Survival | 1 | 2008 | 1098 | 0.010 |
Why?
| | Aged | 1 | 2021 | 25913 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1821 | 0.010 |
Why?
|
|
Masterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|